TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points

OBJECTIVE: To evaluate the onset of efficacy of TEV-48125, a monoclonal antibody against calcitonin gene-related peptide, recently shown to be effective for the preventive treatment of chronic migraine (CM) and high-frequency episodic migraine. METHODS: A randomized placebo-controlled study tested o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bigal, Marcelo E., Dodick, David W., Krymchantowski, Abouch V., VanderPluym, Juliana H., Tepper, Stewart J., Aycardi, Ernesto, Loupe, Pippa S., Ma, Yuju, Goadsby, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932236/
https://www.ncbi.nlm.nih.gov/pubmed/27281531
http://dx.doi.org/10.1212/WNL.0000000000002801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932236/
https://www.ncbi.nlm.nih.gov/pubmed/27281531
http://dx.doi.org/10.1212/WNL.0000000000002801

Ejemplares similares